Northcoast Research Weighs in on Smith & Nephew plc’s FY2018 Earnings (SNN)

Smith & Nephew plc (NYSE:SNN) – Research analysts at Northcoast Research increased their FY2018 EPS estimates for Smith & Nephew in a report released on Monday, November 5th. Northcoast Research analyst D. Keiser now expects that the medical equipment provider will post earnings of $1.90 per share for the year, up from their previous estimate of $1.87. Northcoast Research also issued estimates for Smith & Nephew’s Q4 2019 earnings at $1.08 EPS.

Several other research analysts have also issued reports on the stock. Zacks Investment Research upgraded shares of Smith & Nephew from a “hold” rating to a “buy” rating and set a $40.00 price target for the company in a research note on Wednesday, August 29th. UBS Group lowered shares of Smith & Nephew from a “buy” rating to a “neutral” rating in a research note on Wednesday, August 8th. HSBC lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Tuesday, October 16th. Finally, Canaccord Genuity reiterated a “buy” rating and issued a $42.00 price target on shares of Smith & Nephew in a research note on Monday, August 6th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $41.00.

Shares of Smith & Nephew stock opened at $37.23 on Wednesday. The company has a debt-to-equity ratio of 0.31, a current ratio of 2.13 and a quick ratio of 1.05. The stock has a market capitalization of $16.17 billion, a P/E ratio of 19.59, a price-to-earnings-growth ratio of 3.02 and a beta of 0.58. Smith & Nephew has a 1 year low of $32.22 and a 1 year high of $39.85.

A number of hedge funds have recently made changes to their positions in SNN. Connor Clark & Lunn Investment Management Ltd. grew its position in Smith & Nephew by 248.1% during the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 678,015 shares of the medical equipment provider’s stock valued at $25,446,000 after purchasing an additional 483,215 shares during the last quarter. Dalton Greiner Hartman Maher & Co. grew its position in Smith & Nephew by 180.5% during the 2nd quarter. Dalton Greiner Hartman Maher & Co. now owns 382,612 shares of the medical equipment provider’s stock valued at $14,359,000 after purchasing an additional 246,209 shares during the last quarter. Glenmede Trust Co. NA grew its position in Smith & Nephew by 22.4% during the 2nd quarter. Glenmede Trust Co. NA now owns 981,568 shares of the medical equipment provider’s stock valued at $36,838,000 after purchasing an additional 179,800 shares during the last quarter. Cox Capital Co LLC purchased a new stake in Smith & Nephew during the 2nd quarter valued at about $1,924,000. Finally, CIBC Private Wealth Group LLC grew its position in Smith & Nephew by 38.3% during the 2nd quarter. CIBC Private Wealth Group LLC now owns 96,270 shares of the medical equipment provider’s stock valued at $3,613,000 after purchasing an additional 26,652 shares during the last quarter. 8.53% of the stock is currently owned by institutional investors.

About Smith & Nephew

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

See Also: Growth Stocks, What They Are, What They Are Not

Earnings History and Estimates for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply